Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of Literature
Several guidelines endorsed the indefinite use warfarin or heparin-containing products for acute venous thromboembolism (VTE) treatment and secondary prevention and discouraged the use of direct oral anticoagulants (DOAC) for patients diagnosed with antiphospholipid syndrome (APS). However, adequate...
Main Authors: | Khalid Al Sulaiman SCC-CCP, BCCCP, BCNSP, MBA, Awatif Hafiz PharmD, BCCP, Hisham A. Badreldin PharmD, FCCP, BCPS, BCCP, Ghazwa B. Korayem PharmD, BCPS, Faisal Alsuwayyid PharmD, Abdulrahman Alrashidi, PharmD, Mohammed Alhijris PharmD, Faisal Almutairi, PharmD, Fahad Alharthi PharmD, Saad Alghamdi PharmD, Ahmed Abu Alreesh ClinPharmM.Sc, Ohoud Aljuhani PharmD, BCCCP |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-05-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/23247096221099893 |
Similar Items
-
Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review
and Meta-Analysis
by: Awatif Hafiz PharmD, BCCP, et al.
Published: (2023-08-01) -
Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network
by: Rachel M. Belcher, PharmD, BCCCP, et al.
Published: (2023-01-01) -
Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis
by: Julie Nguyen, PharmD, et al.
Published: (2022-01-01) -
Evaluation of Patient Characteristics Linked to Major Bleeding Events in Patients Prescribed Direct Oral Anticoagulants
by: Dareen M. Kanaan PharmD, MPH, BCCP, et al.
Published: (2023-05-01) -
Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population
by: Denis J. Vanini, PharmD, BCCCP, et al.
Published: (2024-03-01)